Abstract
Background
Although the increased risk of developing pancreatic cancer (PC) in families with a strong history of the disease is well known, characteristics and outcomes of patients with familial PC is not described well.
Aims
This study aims to evaluate outcomes following resection in patients with familial PC.
Methods
We studied 208 patients who underwent resection of PC from 2000 to 2007 and had prospectively completed family history questionnaires for the Biospecimen Resource for Pancreas Research at our institution. We compared clinical characteristics and outcomes of familial and sporadic PC patients.
Results
Familial (N = 15) and sporadic PC patients (N = 193) did not have significantly different demographics, pre-operative CA19-9, pre-operative weight loss, R0 status, or T-staging (all p ≥ 0.05). Familial PC patients had lower pre-operative total serum bilirubin concentrations (p = 0.03) and lesions outside of the pancreatic head more frequently (p = 0.02) than sporadic PC patients. There was no difference in survival at 2 years between familial and sporadic PC patients (p = 0.52).
Conclusions
Familial PC patients appear to develop tumors outside of the pancreatic head more frequently than sporadic PC patients. This difference in tumor distribution may be due to a broader area of cancer susceptibility within the pancreas for familial PC patients.
Similar content being viewed by others
References
Reimer RR, Fraumeni JF, Jr., Ozols RF, Bender R. Pancreatic cancer in father and son. Lancet. Apr 23 1977;1(8017):911
Friedman JM, Fialkow PJ. Familial carcinoma of the pancreas. Clin Genet. May 1976;9(5):463–469.
Appel MF. Hereditary pancreatitis. Review and presentation of an additional kindred. Arch Surg. Jan 1974;108(1):63–65.
MacDermott RP, Kramer P. Adenocarcinoma of the pancreas in four siblings. Gastroenterology. Jul 1973;65(1):137–139.
Lynch HT. Cancer families: Adenocarcinomas (endometrial and colon carcinomas) and multiple primary malignant neoplasms. Recent Results Cancer Res. 1967;12:125–142.
Price TF, Payne RL, Oberleitner MG. Familial pancreatic cancer in south Louisiana. Cancer Nurs. Aug 1996;19(4):275–282.
Fernandez E, La Vecchia C, D’Avanzo B, Negri E, Franceschi S. Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev. Apr-May 1994;3(3):209–212.
Ghadirian P, Boyle P, Simard A, Baillargeon J, Maisonneuve P, Perret C. Reported family aggregation of pancreatic cancer within a population-based case–control study in the Francophone community in Montreal, Canada. Int J Pancreatol. Nov-Dec 1991;10(3–4):183–196.
Lynch HT, Voorhees GJ, Lanspa SJ, McGreevy PS, Lynch JF. Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study. Br J Cancer. Aug 1985;52(2):271–273.
Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz–Jeghers syndrome. Gastroenterology. Dec 2000;119(6):1447–1453.
Goggins M, Schutte M, Lu J, et al. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. Dec 1 1996;56(23):5360–5364
Lynch HT, Fusaro RM, Lynch JF, Brand R. Pancreatic cancer and the FAMMM syndrome. Fam Cancer. 2008;7(1):103–112.
Lowenfels AB, Maisonneuve P, DiMagno EP, et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst. Mar 19 1997;89(6):442–446
Shi C, Hruban RH, Klein AP. Familial pancreatic cancer. Arch Pathol Lab Med. Mar 2009;133(3):365–374.
van der Heijden MS, Brody JR, Dezentje DA, et al. In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor. Clin Cancer Res. Oct 15 2005;11(20):7508–7515
Sato N, Rosty C, Jansen M, et al. STK11/LKB1 Peutz–Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol. Dec 2001;159(6):2017–2022.
Banville N, Geraghty R, Fox E, et al. Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene. Hum Pathol. Nov 2006;37(11):1498–1502.
Wilentz RE, Goggins M, Redston M, et al. Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. Am J Pathol. May 2000;156(5):1641–1651.
Nakata B, Wang YQ, Yashiro M, et al. Prognostic value of microsatellite instability in resectable pancreatic cancer. Clin Cancer Res. Aug 2002;8(8):2536–2540.
Permuth-Wey J, Egan KM. Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis. Fam Cancer. Sep 2 2008.
Tersmette AC, Petersen GM, Offerhaus GJ, et al. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res. Mar 2001;7(3):738–744.
Yeo TP, Hruban RH, Brody J, Brune K, Fitzgerald S, Yeo CJ. Assessment of “gene-environment” interaction in cases of familial and sporadic pancreatic cancer. J Gastrointest Surg. Aug 2009;13(8):1487–1494.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barton, J.G., Schnelldorfer, T., Lohse, C.M. et al. Patterns of Pancreatic Resection Differ Between Patients with Familial and Sporadic Pancreatic Cancer. J Gastrointest Surg 15, 836–842 (2011). https://doi.org/10.1007/s11605-011-1417-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-011-1417-x